Protokinetix Ownership

PKTX Stock  USD 0.01  0.0008  9.88%   
Protokinetix owns a total of 316.85 Million outstanding shares. Protokinetix has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Protokinetix in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Protokinetix, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protokinetix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Protokinetix Pink Sheet Ownership Analysis

About 31.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Protokinetix had not issued any dividends in recent years. The entity had 5:2 split on the 29th of April 2002. ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins or anti-aging glycoproteins . ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio. Protokinetix is traded on OTC Exchange in the United States.The quote for Protokinetix is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Protokinetix contact Clarence Smith at 740 434 5041 or learn more at https://www.protokinetix.com.

Protokinetix Outstanding Bonds

Protokinetix issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Protokinetix uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Protokinetix bonds can be classified according to their maturity, which is the date when Protokinetix has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protokinetix Pink Sheet Analysis

When running Protokinetix's price analysis, check to measure Protokinetix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protokinetix is operating at the current time. Most of Protokinetix's value examination focuses on studying past and present price action to predict the probability of Protokinetix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protokinetix's price. Additionally, you may evaluate how the addition of Protokinetix to your portfolios can decrease your overall portfolio volatility.